Jamjoom Pharma's net profit climbed 5.1% to $110.5 million (SAR 416.05 million) in the first nine months of 2026, driven by revenue growth and gross margin expansion supported by production efficiencies and a favorable product and geographic mix. Performance and guidance Revenue for the nine-month period increased 7.1% to $340 million (SAR 1.28 billion) versus the same period in 2025, driven mainly by continued growt